JP2009527498A5 - - Google Patents

Download PDF

Info

Publication number
JP2009527498A5
JP2009527498A5 JP2008555524A JP2008555524A JP2009527498A5 JP 2009527498 A5 JP2009527498 A5 JP 2009527498A5 JP 2008555524 A JP2008555524 A JP 2008555524A JP 2008555524 A JP2008555524 A JP 2008555524A JP 2009527498 A5 JP2009527498 A5 JP 2009527498A5
Authority
JP
Japan
Prior art keywords
peptide
seq
capcna
amino acid
peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008555524A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009527498A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/062335 external-priority patent/WO2007098415A2/en
Publication of JP2009527498A publication Critical patent/JP2009527498A/ja
Publication of JP2009527498A5 publication Critical patent/JP2009527498A5/ja
Pending legal-status Critical Current

Links

JP2008555524A 2006-02-17 2007-02-16 癌におけるcaPCNA相互作用のペプチドによる抑制 Pending JP2009527498A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US74331306P 2006-02-17 2006-02-17
PCT/US2007/062335 WO2007098415A2 (en) 2006-02-17 2007-02-16 Peptide based inhibition of capcna protein-protein interactions in cancer

Publications (2)

Publication Number Publication Date
JP2009527498A JP2009527498A (ja) 2009-07-30
JP2009527498A5 true JP2009527498A5 (cg-RX-API-DMAC7.html) 2009-10-22

Family

ID=38235155

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008555524A Pending JP2009527498A (ja) 2006-02-17 2007-02-16 癌におけるcaPCNA相互作用のペプチドによる抑制

Country Status (9)

Country Link
US (3) US8653039B2 (cg-RX-API-DMAC7.html)
EP (1) EP1989225A2 (cg-RX-API-DMAC7.html)
JP (1) JP2009527498A (cg-RX-API-DMAC7.html)
CN (1) CN101384618A (cg-RX-API-DMAC7.html)
AU (1) AU2007217037A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0707948A2 (cg-RX-API-DMAC7.html)
CA (1) CA2638866C (cg-RX-API-DMAC7.html)
EA (1) EA200801847A1 (cg-RX-API-DMAC7.html)
WO (1) WO2007098415A2 (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA200801847A1 (ru) * 2006-02-17 2009-02-27 Индиана Юниверсити Рисерч Энд Текнолоджи Корпорейшн ПЕПТИДНОЕ ИНГИБИРОВАНИЕ ВЗАИМОДЕЙСТВИЯ caPCNA ПРИ РАКЕ
WO2008036929A2 (en) * 2006-09-21 2008-03-27 Alnylam Pharmaceuticals, Inc. Complex for transferring an anionic substance into a cell
GB0803352D0 (en) 2008-02-22 2008-04-02 Ntnu Technology Transfer As Oligopeptidic compounds and uses thereof
CA2732737C (en) * 2008-07-24 2019-03-05 Indiana University Research And Technology Corporation Cancer peptide therapeutics
FR2942798B1 (fr) * 2009-03-05 2011-04-08 Centre Nat Rech Scient Peptides utilisables pour le traitement de la leucemie lymphoide chronique
WO2011044374A1 (en) * 2009-10-07 2011-04-14 Indiana University Research And Technology Corporation Capcna peptide therapeutics for cancer
EP2538959A1 (en) * 2010-02-24 2013-01-02 Institut National de la Santé et de la Recherche Médicale Compounds for the treatment of inflammation and neutropenia
JP2013522613A (ja) * 2010-03-18 2013-06-13 アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル 化学療法に対する応答性を予測するための方法
US9475840B2 (en) 2012-02-27 2016-10-25 Universitat De Barcelona Protease-resistant compounds useful as shuttles through the blood-brain barrier and shuttle-cargo constructs
GB201214007D0 (en) * 2012-08-07 2012-09-19 Scancell Ltd Anti-tumour immune responses to modified self-epitopes
US10420840B2 (en) * 2015-04-10 2019-09-24 Rll, Llc Anticancer therapeutic agents
JP2020514256A (ja) * 2016-12-15 2020-05-21 ザ ナショナル インスティチュート フォー バイオテクノロジー イン ザ ネゲヴ,リミテッド 抗pcnaモノクローナル抗体及びその使用
GB201815041D0 (en) 2018-09-14 2018-10-31 Scancell Ltd Epitopes

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5935797A (en) 1994-06-16 1999-08-10 Stanford University Interaction of MHC Class II proteins with members of the PCNA family of proteins
GB9509557D0 (en) * 1995-05-11 1995-07-05 Univ Dundee PCNA binding substance
JP2002518341A (ja) * 1998-06-15 2002-06-25 アーチ・デヴェロップメント・コーポレイション 放射線療法と抗血管形成因子の組み合わせ
US7294471B2 (en) 2002-02-27 2007-11-13 Cskeys, Llc Method for purifying cancer-specific proliferating cell nuclear antigen
MX2007013584A (es) 2005-04-27 2008-04-22 Univ Indiana Res & Tech Corp Anticuerpos de isoforma de cspcna y sus usos.
DE602006021178D1 (de) 2005-06-27 2011-05-19 Univ Indiana Res & Tech Corp Cspcna-isoform-modifikationen und anwendungen davon
EA200801847A1 (ru) * 2006-02-17 2009-02-27 Индиана Юниверсити Рисерч Энд Текнолоджи Корпорейшн ПЕПТИДНОЕ ИНГИБИРОВАНИЕ ВЗАИМОДЕЙСТВИЯ caPCNA ПРИ РАКЕ

Similar Documents

Publication Publication Date Title
JP7007423B2 (ja) 細胞透過性ペプチド、それを含んだコンジュゲート、及びそれを含んだ組成物
JP2022078262A (ja) 細胞透過性ペプチド、それを含んだコンジュゲート、及びそれを含んだ組成物
ES2381206T3 (es) Inhibidores peptídicos con permeabilidad celular de la ruta de transducción de la señal JNK
CN101263157B (zh) Jnk信号转导通路的细胞通透肽抑制剂
US9527895B2 (en) CAPCNA peptide therapeutics for cancer
US20160324976A1 (en) Peptide having cell membrane penetrating activity
US20080090770A1 (en) Modulation of Muc1 Mediated Signal Transduction
US20120142613A1 (en) Cell-Permeable Peptide Inhibitors of the JNK Signal Transduction Pathway
EP2913057B1 (en) Cancer peptide therapeutics
CN104147591A (zh) Jnk信号转导通路的细胞可渗透性肽抑制剂用于治疗各种疾病的应用
JP2009527498A (ja) 癌におけるcaPCNA相互作用のペプチドによる抑制
US20130157260A1 (en) Identification of compounds that regulate apoptosis
US20190201483A1 (en) ATF5 Peptide Variants and Uses Thereof
US20080274956A1 (en) Fusion Protein Comprising a Bh3-Domain of a Bh3-Only Protein
CN101300270A (zh) 未活化的Wnt抑制多肽及其制备方法
US20130237476A1 (en) Adipose tissue targeted peptides
US9567369B2 (en) Method of treating metastatic cancer
JP2010254699A (ja) Fas関連因子1(fasassociatedfactor1)
CN113166216A (zh) 源自人lrrc24蛋白的跨膜结构域
Guo et al. Effects of the TAT peptide orientation and relative location on the protein transduction efficiency
CN105555796A (zh) 抑制肽对治疗炎性疾病的用途
WO2014178680A1 (ko) Hsp 발현 억제 펩티드 및 이를 포함하는 조성물
WO2011079431A1 (zh) 具有端粒酶抑制活性的融合蛋白、其制备方法和用途
JP2008505846A (ja) 悪性哺乳動物細胞および形質転換哺乳動物細胞に対して選択的に致死性を有するペプチド
CN101010337A (zh) Fas相关因子1